Manchester Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,813
| Closed | -$44K | – | 516 |
|
|
2017
Q3 | $44K | Hold |
3,813
| – | – | 0.01% | 353 |
|
|
2017
Q2 | $37K | Hold |
3,813
| – | – | 0.01% | 371 |
|
|
2017
Q1 | $92K | Hold |
3,813
| – | – | 0.01% | 287 |
|
|
2016
Q4 | $122K | Hold |
3,813
| – | – | 0.02% | 246 |
|
|
2016
Q3 | $191K | Hold |
3,813
| – | – | 0.03% | 195 |
|
|
2016
Q2 | $162K | Hold |
3,813
| – | – | 0.02% | 223 |
|
|
2016
Q1 | $251K | Hold |
3,813
| – | – | 0.03% | 173 |
|
|
2015
Q4 | $237K | Hold |
3,813
| – | – | 0.03% | 194 |
|
|
2015
Q3 | $255K | Hold |
3,813
| – | – | 0.04% | 169 |
|
|
2015
Q2 | $371K | Hold |
3,813
| – | – | 0.06% | 145 |
|
|
2015
Q1 | $356K | Hold |
3,813
| – | – | 0.06% | 144 |
|
|
2014
Q4 | $339K | Hold |
3,813
| – | – | 0.04% | 239 |
|
|
2014
Q3 | $263K | Hold |
3,813
| – | – | 0.04% | 281 |
|
|
2014
Q2 | $219K | Hold |
3,813
| – | – | 0.03% | 347 |
|
|
2014
Q1 | $151K | Hold |
3,813
| – | – | 0.02% | 414 |
|
|
2013
Q4 | $160K | Buy |
+3,813
| New | +$160K | 0.02% | 382 |
|